MGFZX
Price
$10.03
Change
+$0.07 (+0.70%)
Updated
Dec 24 closing price
NPFCX
Price
$59.28
Change
+$0.52 (+0.88%)
Updated
Dec 24 closing price
Ad is loading...

MGFZX vs NPFCX

Header iconMGFZX vs NPFCX Comparison
Open Charts MGFZX vs NPFCXBanner chart's image
MassMutual Global I
Price$10.03
Change+$0.07 (+0.70%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective C
Price$59.28
Change+$0.52 (+0.88%)
VolumeN/A
CapitalizationN/A
MGFZX vs NPFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGFZX vs. NPFCX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGFZX is a Buy and NPFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 146B vs. MGFZX (179M). NPFCX pays higher dividends than MGFZX: NPFCX (0.20) vs MGFZX (0.00). MGFZX was incepted earlier than NPFCX: MGFZX (11 years) vs NPFCX (24 years). NPFCX is a more actively managed with annual turnover of: 17.00 vs. MGFZX (10.00). MGFZX has a lower initial minimum investment than NPFCX: MGFZX (0) vs NPFCX (250). NPFCX annual gain was more profitable for investors over the last year : 13.85 vs. MGFZX (3.62). NPFCX return over 5 years is better than : 30.89 vs. MGFZX (-27.89).
MGFZXNPFCXMGFZX / NPFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years24 years-
Gain YTD3.29613.17325%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets179M146B0%
Annual Yield % from dividends0.000.20-
Returns for 1 year3.6213.8526%
Returns for 3 years-42.02-4.55924%
Returns for 5 years-27.8930.89-90%
Returns for 10 years-26.9967.02-40%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TUYA1.810.02
+1.12%
Tuya
AB36.800.31
+0.85%
AllianceBernstein Holding LP
ABTS0.45N/A
+0.67%
Abits Group
NVR8259.3736.85
+0.45%
NVR
HRTX1.58-0.02
-1.25%
Heron Therapeutics